Aishwarya Nair's Profile

Aishwarya Nair

Aishwarya is currently studying Doctor of Pharmacy (Pharm D) at Pune University. In academics her position stands within first five ranks in Pune university exams. She has also done internship at a Mumbai based hospital during her vacations. She was posted as a critical care clinical pharmacist. She view more..

Written / Edited / Medically Reviewed

CDC Shortens COVID-19 Quarantine Period to 7-10 Days

CDC Shortens COVID-19 Quarantine Period to 7-10 Days

CDC announces quarantine period now reduced to 7-10 days along with certain conditions. CDC also requests the public to postpone their winter travel. Stay home stay safe.

Coronavirus News
Setmelanotide - First Drug to Treat Rare Genetic Causes of Severe Obesity Approved by FDA

Setmelanotide - First Drug to Treat Rare Genetic Causes of Severe Obesity Approved by FDA

Setmelanotide has been approved by the US FDA for weight to treat rare genetic causes of severe obesity in adults and children as young as 6 years of age.

Drug News
New Experimental Drug Helps Treat Antibiotic Resistant Bacteria

New Experimental Drug Helps Treat Antibiotic Resistant Bacteria

An experimental drug being tested to treat neurodegenerative disease may help fight against life- threatening antibiotic resistant bacteria, suggests a study

Drug News
Discontinuing Tyrosine Kinase Inhibitors can Improve Outcomes in Leukemia Patients

Discontinuing Tyrosine Kinase Inhibitors can Improve Outcomes in Leukemia Patients

Discontinuing Tyrosine Kinase inhibitor (TKI) in patients suffering from chronic myeloid leukemia (CML) has shown better patient reported outcomes.

Cancer News
MHRA Issues a Drug Safety Alert After Fatal Cases of Liver Injury With Lung Antifibrotics

MHRA Issues a Drug Safety Alert After Fatal Cases of Liver Injury With Lung Antifibrotics

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety alert for the use of Pirfenidone as it is shown to cause severe liver toxicity.

Drug News